Startups
We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, rare liver, and rare kidney diseases. Our proprietary DARGER™ platform enables both gene upregulation and downregulation using novel antisense oligonucleotide (ASO) and small interfering RNA (siRNA) approaches.
Overview
Location
United States, California, San Diego
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Arnatar Therapeutics | “arnatar” |
Reviews 0
FAQ about ARNATAR THERAPEUTICS
What has the press written about ARNATAR THERAPEUTICS?
Parsers VC has collected 2 articles mentioning ARNATAR THERAPEUTICS, among them “Arnatar Therapeutics”.
Is ARNATAR THERAPEUTICS still active?
Yes, ARNATAR THERAPEUTICS is active; its latest activity on Parsers VC dates from Nov 11, 2025.